In line with these findings, a study found that suppression of endogenous wild‐type tau prevented cognitive deficits in an AD mouse model expressing human mutant APP without detectable changes in plaque pathology (Roberson et al. 2007). The gene discussed is MAPT; the disease is Cognitive impairment.